Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00550004
What this trial is testing

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine

Who this might be right for
Pancreatic Cancer
SciClone Pharmaceuticals 153
Testing effectiveness (Phase 2)Looking for participantsNCT05944237
What this trial is testing

HTL0039732 in Participants With Advanced Solid Tumours

Who this might be right for
NeoplasmsProstatic Neoplasms, Castration-ResistantStomach Neoplasms+11 more
Cancer Research UK 150
Early research (Phase 1)Study completedNCT00379639
What this trial is testing

Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors

Who this might be right for
Pancreatic Cancer
Celgene 36
Testing effectiveness (Phase 2)Study completedNCT03717298
What this trial is testing

Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Adenocarcinoma of the PancreasPancreatic CancerAdvanced Cancer+6 more
Catalysis SL 30
Testing effectiveness (Phase 2)Looking for participantsNCT07619521
What this trial is testing

Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v8+2 more
National Cancer Institute (NCI) 31
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT04387071
What this trial is testing

CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more
University of Southern California 2
Large-scale testing (Phase 3)Study completedNCT00030732
What this trial is testing

Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Swiss Cancer Institute 319
Not applicableStudy completedNCT06378580
What this trial is testing

The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Luo Cong 72
Early research (Phase 1)Looking for participantsNCT07106827
What this trial is testing

GV20-0251 in Advanced or Refractory Solid Tumors

Who this might be right for
HCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more
West China Hospital 10
Early research (Phase 1)Study completedNCT02720666
What this trial is testing

K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability

Who this might be right for
Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 12
Not applicableLooking for participantsNCT05764720
What this trial is testing

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

Who this might be right for
Pancreatic Cancer
Varian, a Siemens Healthineers Company 134
Early research (Phase 1)Ended earlyNCT01929941
What this trial is testing

An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies

Who this might be right for
Solid TumorHodgkin's LymphomaNHL (Non-Hodgkin Lymphoma)+5 more
Incyte Corporation 5
Testing effectiveness (Phase 2)Study completedNCT02259725
What this trial is testing

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
University of Southern California 3
Not applicableWithdrawnNCT01795274
What this trial is testing

Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial

Who this might be right for
Locally Advanced Pancreatic Cancer
University Hospital Heidelberg
Early research (Phase 1)Looking for participantsNCT06861543
What this trial is testing

The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Peking Union Medical College Hospital 18
Early research (Phase 1)Study completedNCT01048320
What this trial is testing

Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Royal Marsden NHS Foundation Trust 36
Testing effectiveness (Phase 2)Study completedNCT00003332
What this trial is testing

Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health 36
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00005858
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+3 more
University of Maryland, Baltimore 25
Next Page